The EMA has announced an EU-wide suspension of fenspiride medicines due to a potential risk of heart rhythm problems.Original Article
You may also like
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.